Report urges pharma companies to utilise synthetic data in clinical trials
A new report from Phesi and Accenture is encouraging pharmaceutical companies to utilise synthetic data in clinical trials.
We use necessary cookies to make our site work. We'd also like to set analytical cookies to help us improve our service, but we'd like your permission first. Please choose which cookies you're happy for us to set.